TPM
IDXX icon

Triasima Portfolio Management’s Idexx Laboratories IDXX Stock Holding History

Triasima Portfolio Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-478
Closed -$315K – 167
2021
Q4 		$315K Buy
478
+33
+7% +$20.7K 0.02% 144
2021
Q3 		$277K Buy
+445
New +$299K 0.01% 143

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Triasima Portfolio Management's IDXX Position: Q1 2022 in Review

Triasima Portfolio Management sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 478 shares — an estimated $315K sold.

Triasima Portfolio Management first reported a position in IDXX in Q3 2021 and held it in 2 quarters. The position peaked at $315K in Q4 2021. 1,032 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

  • Triasima Portfolio Management reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
  • Triasima Portfolio Management sold 478 Idexx Laboratories shares in Q1 2022, an estimated $315K.
  • Triasima Portfolio Management first reported a position in Idexx Laboratories in Q3 2021 and held it in 2 quarters.
  • Triasima Portfolio Management's Idexx Laboratories position peaked at $315K in Q4 2021.
  • 1,032 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on Triasima Portfolio Management's 13F filing for Q1 2022, filed 20 Jul 2022.